This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Graham, S. J. Articles by Szabadi, E. Search for Related Content PubMed PubMed Citation Articles by Graham, S. J. Articles by Szabadi, E. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB CLOZAPINE HALOPERIDOL Social Bookmarking                         What's this?

Effects of haloperidol and clozapine on prepulse inhibition of the acoustic startle response and the N1/P2 auditory evoked potential in man

R. W. Langley

Division of Psychiatry, University of Nottingham, Nottingham, UK

C. M. Bradshaw

Psychopharmacology Section Division of Psychiatry University of Nottingham Room B109, Medical School Queen's Medical Centre Nottingham NG7 2UH UK c.m.bradshaw{at}nottingham.ac.uk

E. Szabadi

Division of Psychiatry, University of Nottingham, Nottingham, UK

Contraction of the orbicularis oculi muscle in response to a sudden loud sound (acoustic startle response) and the N1/P2 component of the auditory evoked potential are both attenuated when a brief low-intensity stimulus is presented 30–500 ms before the ‘startle-eliciting’ stimulus (prepulse inhibition). Here, we report the effects of the ‘conventional’ antipsychotic drug haloperidol and the ‘atypical’ antipsychotic clozapine on these responses. Fifteen males (aged 19–54 years) participated in four sessions at 7-day intervals, in which they received clozapine 3 mg, clozapine 6 mg, haloperidol 3 mg and placebo, according to a balanced double-blind design. Electromyographic (EMG) responses of the orbicularis oculi muscle and N1/P2 auditory evoked potentials were recorded in a 20-min session, 3 h after treatment. Subjects received 40 trials in which 1-kHz sounds were presented: (i) 40 ms, 115 dB (‘pulse alone’ trials) and (ii) 40 ms, 85 dB, followed after 120 ms by 40 ms, 115 dB (‘prepulse/pulse’ trials). Mean amplitudes of the EMG response and the N1/P2 potential were derived from the pulse-alone trials and, in each case, percentage prepulse inhibition was calculated. Serum prolactin was measured after each treatment, and autonomic (heart rate, blood pressure, salivation) and psychological (visual analogue self-ratings of mood and alertness, critical flicker fusion frequency) measures were taken before and after each treatment. Clozapine 6 mg significantly reduced the amplitude of the EMG response without altering its inhibition by prepulses. Clozapine 6 mg did not affect the amplitude of the N1/P2 potential, but significantly attenuated prepulse inhibition of that response. Clozapine 3 mg and haloperidol had no significant effect on either response. Clozapine 3 mg and 6 mg, but not haloperidol, reduced subjective alertness and critical flicker fusion frequency. Clozapine 6 mg reduced salivation. Haloperidol, but not clozapine, elevated serum prolactin levels. These results confirm that prepulse inhibition of the startle response and of the N1/P2 complex have different pharmacological sensitivities. The abililty of clozapine to attenuate the startle response may reflect its sedative action. The basis of the abililty of clozapine to suppress prepulse inhibition of the N1/P2 potential remains uncertain.

Key Words: acoustic startle response • antipsychotics • auditory evoked potential • clozapine • eyeblink • haloperidol • N1/P2 complex • prepulse inhibition

Journal of Psychopharmacology, Vol. 15, No. 4, 243-250 (2001)
DOI: 10.1177/026988110101500411


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				P. A. Csomor, B. K. Yee, J. Feldon, A. Theodoridou, E. Studerus, and F. X. Vollenweider Impaired Prepulse Inhibition and Prepulse-Elicited Reactivity but Intact Reflex Circuit Excitability in Unmedicated Schizophrenia Patients: a Comparison With Healthy Subjects and Medicated Schizophrenia Patients Schizophr Bull, January 1, 2009; 35(1): 244 - 255. [Abstract] [Full Text] [PDF]

				S. J. Graham, J. C. Scaife, R. W. Langley, C. M. Bradshaw, E. Szabadi, L. Xi, T. Crumley, N. Calder, K. Gottesdiener, and J. A. Wagner Effects of lorazepam on fear-potentiated startle responses in man J Psychopharmacol, May 1, 2005; 19(3): 249 - 258. [Abstract] [PDF]

				S. L. Barrett, R. Bell, D. Watson, and D. J. King Effects of Amisulpride, Risperidone and Chlorpromazine on Auditory and Visual Latent Inhibition, Prepulse Inhibition, Executive Function and Eye Movements in Healthy Volunteers J Psychopharmacol, June 1, 2004; 18(2): 156 - 172. [Abstract] [PDF]

				S. J. Graham, J. C. Scaife, A. M. B. Verduzco, R. W. Langley, C. M. Bradshaw, and E. Szabadi Effects of Quetiapine and Haloperidol on Prepulse Inhibition of the Acoustic Startle (Eyeblink) Response and the N1/P2 Auditory Evoked Response in Man J Psychopharmacol, June 1, 2004; 18(2): 173 - 180. [Abstract] [PDF]